NSCLC
Conditions
Interventions
Treatment group:Xuefu zhuyu capsule
Treatment group:Routine treatment of postoperative Western Medicine
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-75 years old (including 18 and 75 years old); 2. Those who underwent thoracoscopic lobectomy; 3. Patients with postoperative pathological diagnosis of primary lung cancer or precancerous lesions; 4. No chest pain before operation, postoperative pain within 3 months, and NRS score = 4; 5. Those who meet the TCM diagnostic criteria of qi stagnation and blood stasis syndrome; 6. Voluntarily participate in clinical research and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who meet the diagnostic criteria of primary bronchial lung cancer and have been treated with radiotherapy, chemotherapy, targeted therapy and traditional Chinese medicine in the first 3 months; 2. Have mental illness, such as unconsciousness and communication disorder; 3. Patients with serious heart, liver, kidney and cerebrovascular diseases; 4. Allergic constitution or allergic to the ingredients of Xuefu Zhuyu Capsule and various drugs; 5. Those who participated in other clinical studies within 3 months before screening; 6. Pregnant or ready for pregnancy, lactating women; 7. The researcher considers it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;QLQ-C30;CRP;HAMD;HAMA; | — |
Countries
China
Contacts
Public ContactFeng Cuiling
Outcome results
None listed